Medical Care
Global Peptide Therapeutics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
- Jun 12, 25
- ID: 307042
- Pages: 143
- Figures: 139
- Views: 4
In 2024, the global market size of Peptide Therapeutics was estimated to be worth US$ 41000 million and is forecast to reach approximately US$ 74320 million by 2031 with a CAGR of 9.0% during the forecast period 2025-2031.
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics.
The Peptide Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Segment by Type
Injection
Oral
Other
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Peptide Therapeutics in global and regional level.
Chapter 3: Detailed analysis of Peptide Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Therapeutics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
Peptides are short chains of amino acid monomers linked by peptide (amide) bonds, the covalent chemical bonds formed when the carboxyl group of one amino acid reacts with the amino group of another.
Global Peptide Therapeutics key players include Sanofi, Novo Nordisk, Takeda, Eli Lilly, Ipsen, etc. Global top five manufacturers hold a share about 65%.
North America is the largest market, with a share about 55%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Injection is the largest segment, with a share about 70%. And in terms of application, the largest application is Cancer, followed by Central Nervous System.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peptide Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide Therapeutics.
The Peptide Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation
By Company
Sanofi
Teva
Novo Nordisk
Takeda
Eli Lilly
AstraZeneca
Novartis
AbbVie
Ipsen
Ferring
Merck
The Medicines
J & J
Segment by Type
Injection
Oral
Other
Segment by Application
Cancer
Metabolic Disorders
Central Nervous System
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Peptide Therapeutics in global and regional level.
Chapter 3: Detailed analysis of Peptide Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peptide Therapeutics revenue, gross margin, and recent development, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: Research Findings and Conclusion
1 Study Coverage
1.1 Peptide Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peptide Therapeutics Market Size Estimates and Forecasts
2.2 Peptide Therapeutics Market Size by Region: 2024 Versus 2031
2.2.1 Global Peptide Therapeutics Revenue by Region: 2020-2025
2.2.2 Global Peptide Therapeutics Revenue Forecast by Region (2026-2031)
2.2.3 Global Peptide Therapeutics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Peptide Therapeutics Revenue by Type (2020-2031)
3.1.2 Global Peptide Therapeutics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Peptide Therapeutics Revenue by Application (2020-2031)
3.2.2 Global Peptide Therapeutics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Injection of Peptide Therapeutics Revenue Market Share by Application
3.3.2 Oral of Peptide Therapeutics Revenue Market Share by Application
3.3.3 Other of Peptide Therapeutics Revenue Market Share by Application
4 Global Peptide Therapeutics by Company
4.1 Global Peptide Therapeutics Revenue by Company (2020-2025)
4.2 Global Peptide Therapeutics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Peptide Therapeutics Companies around the World: Ranking by Revenue
4.3.2 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Peptide Therapeutics Companies Headquarters & Product Type
4.4.1 Global Peptide Therapeutics Companies Headquarters
4.4.2 Date of International Companies Enter into Peptide Therapeutics Market
4.4.3 Global Peptide Therapeutics Companies Product & Service
4.4.4 Injection Revenue Market Share of Peptide Therapeutics by Company
4.4.5 Oral Revenue Market Share of Peptide Therapeutics by Company
4.4.6 Other Revenue Market Share of Peptide Therapeutics by Company
4.5 Global Peptide Therapeutics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi
5.1.1 Sanofi Corporation Information
5.1.2 Sanofi Description, Business Overview
5.1.3 Sanofi Peptide Therapeutics Products Offered
5.1.4 Sanofi Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Peptide Therapeutics Revenue by Product in 2024
5.1.6 Sanofi Peptide Therapeutics Revenue by Application in 2024
5.1.7 Sanofi Peptide Therapeutics Revenue by Geographic Area in 2024
5.1.8 Sanofi Recent Developments
5.2 Teva
5.2.1 Teva Corporation Information
5.2.2 Teva Description, Business Overview
5.2.3 Teva Peptide Therapeutics Products Offered
5.2.4 Teva Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.2.5 Teva Peptide Therapeutics Revenue by Product in 2024
5.2.6 Teva Peptide Therapeutics Revenue by Application in 2024
5.2.7 Teva Peptide Therapeutics Revenue by Geographic Area in 2024
5.2.8 Teva Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Corporation Information
5.3.2 Novo Nordisk Description, Business Overview
5.3.3 Novo Nordisk Peptide Therapeutics Products Offered
5.3.4 Novo Nordisk Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.3.5 Novo Nordisk Peptide Therapeutics Revenue by Product in 2024
5.3.6 Novo Nordisk Peptide Therapeutics Revenue by Application in 2024
5.3.7 Novo Nordisk Peptide Therapeutics Revenue by Geographic Area in 2024
5.3.8 Novo Nordisk Recent Developments
5.4 Takeda
5.4.1 Takeda Corporation Information
5.4.2 Takeda Description, Business Overview
5.4.3 Takeda Peptide Therapeutics Products Offered
5.4.4 Takeda Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.4.5 Takeda Peptide Therapeutics Revenue by Product in 2024
5.4.6 Takeda Peptide Therapeutics Revenue by Application in 2024
5.4.7 Takeda Peptide Therapeutics Revenue by Geographic Area in 2024
5.4.8 Takeda Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Corporation Information
5.5.2 Eli Lilly Description, Business Overview
5.5.3 Eli Lilly Peptide Therapeutics Products Offered
5.5.4 Eli Lilly Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.5.5 Eli Lilly Peptide Therapeutics Revenue by Product in 2024
5.5.6 Eli Lilly Peptide Therapeutics Revenue by Application in 2024
5.5.7 Eli Lilly Peptide Therapeutics Revenue by Geographic Area in 2024
5.5.8 Eli Lilly Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Corporation Information
5.6.2 AstraZeneca Description, Business Overview
5.6.3 AstraZeneca Peptide Therapeutics Products Offered
5.6.4 AstraZeneca Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.6.5 AstraZeneca Peptide Therapeutics Revenue by Product in 2024
5.6.6 AstraZeneca Peptide Therapeutics Revenue by Application in 2024
5.6.7 AstraZeneca Peptide Therapeutics Revenue by Geographic Area in 2024
5.6.8 AstraZeneca Recent Developments
5.7 Novartis
5.7.1 Novartis Corporation Information
5.7.2 Novartis Description, Business Overview
5.7.3 Novartis Peptide Therapeutics Products Offered
5.7.4 Novartis Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.7.5 Novartis Peptide Therapeutics Revenue by Product in 2024
5.7.6 Novartis Peptide Therapeutics Revenue by Application in 2024
5.7.7 Novartis Peptide Therapeutics Revenue by Geographic Area in 2024
5.7.8 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Corporation Information
5.8.2 AbbVie Description, Business Overview
5.8.3 AbbVie Peptide Therapeutics Products Offered
5.8.4 AbbVie Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.8.5 AbbVie Peptide Therapeutics Revenue by Product in 2024
5.8.6 AbbVie Peptide Therapeutics Revenue by Application in 2024
5.8.7 AbbVie Peptide Therapeutics Revenue by Geographic Area in 2024
5.8.8 AbbVie Recent Developments
5.9 Ipsen
5.9.1 Ipsen Corporation Information
5.9.2 Ipsen Description, Business Overview
5.9.3 Ipsen Peptide Therapeutics Products Offered
5.9.4 Ipsen Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.9.5 Ipsen Peptide Therapeutics Revenue by Product in 2024
5.9.6 Ipsen Peptide Therapeutics Revenue by Application in 2024
5.9.7 Ipsen Peptide Therapeutics Revenue by Geographic Area in 2024
5.9.8 Ipsen Recent Developments
5.10 Ferring
5.10.1 Ferring Corporation Information
5.10.2 Ferring Description, Business Overview
5.10.3 Ferring Peptide Therapeutics Products Offered
5.10.4 Ferring Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.10.5 Ferring Peptide Therapeutics Revenue by Product in 2024
5.10.6 Ferring Peptide Therapeutics Revenue by Application in 2024
5.10.7 Ferring Peptide Therapeutics Revenue by Geographic Area in 2024
5.10.8 Ferring Recent Developments
5.11 Merck
5.11.1 Merck Corporation Information
5.11.2 Merck Description, Business Overview
5.11.3 Merck Peptide Therapeutics Products Offered
5.11.4 Merck Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.11.5 Merck Peptide Therapeutics Revenue by Product in 2024
5.11.6 Merck Peptide Therapeutics Revenue by Application in 2024
5.11.7 Merck Peptide Therapeutics Revenue by Geographic Area in 2024
5.11.8 Merck Recent Developments
5.12 The Medicines
5.12.1 The Medicines Corporation Information
5.12.2 The Medicines Description, Business Overview
5.12.3 The Medicines Peptide Therapeutics Products Offered
5.12.4 The Medicines Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.12.5 The Medicines Peptide Therapeutics Revenue by Product in 2024
5.12.6 The Medicines Peptide Therapeutics Revenue by Application in 2024
5.12.7 The Medicines Peptide Therapeutics Revenue by Geographic Area in 2024
5.12.8 The Medicines Recent Developments
5.13 J & J
5.13.1 J & J Corporation Information
5.13.2 J & J Description, Business Overview
5.13.3 J & J Peptide Therapeutics Products Offered
5.13.4 J & J Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.13.5 J & J Peptide Therapeutics Revenue by Product in 2024
5.13.6 J & J Peptide Therapeutics Revenue by Application in 2024
5.13.7 J & J Peptide Therapeutics Revenue by Geographic Area in 2024
5.13.8 J & J Recent Developments
6 North America
6.1 North America Peptide Therapeutics Market Size YoY Growth 2020-2031
6.2 North America Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
6.3 North America Peptide Therapeutics Revenue by Type (2020-2025)
6.4 North America Peptide Therapeutics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Peptide Therapeutics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Peptide Therapeutics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Peptide Therapeutics Revenue by Type (2020-2025)
7.4 Asia-Pacific Peptide Therapeutics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Peptide Therapeutics Market Size YoY Growth 2020-2031
8.2 Europe Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
8.3 Europe Peptide Therapeutics Revenue by Type (2020-2025)
8.4 Europe Peptide Therapeutics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Peptide Therapeutics Market Size YoY Growth 2020-2031
9.2 Latin America Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Peptide Therapeutics Revenue by Type (2020-2025)
9.4 Latin America Peptide Therapeutics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Peptide Therapeutics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Peptide Therapeutics Revenue by Type (2020-2025)
10.4 Middle East and Africa Peptide Therapeutics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Peptide Therapeutics Supply Chain Analysis
11.2 Peptide Therapeutics Key Raw Materials and Upstream Suppliers
11.3 Peptide Therapeutics Clients Analysis
11.4 Peptide Therapeutics Sales Channel and Sales Model Analysis
11.4.1 Peptide Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Peptide Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Peptide Therapeutics Distributors
12 Peptide Therapeutics Market Dynamics
12.1 Peptide Therapeutics Industry Trends
12.2 Peptide Therapeutics Market Drivers
12.3 Peptide Therapeutics Market Challenges
12.4 Peptide Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1.1 Peptide Therapeutics Product Introduction
1.2 Market by Type
1.2.1 Global Peptide Therapeutics Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Injection
1.2.3 Oral
1.2.4 Other
1.3 Market by Application
1.3.1 Global Peptide Therapeutics Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Central Nervous System
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Peptide Therapeutics Market Size Estimates and Forecasts
2.2 Peptide Therapeutics Market Size by Region: 2024 Versus 2031
2.2.1 Global Peptide Therapeutics Revenue by Region: 2020-2025
2.2.2 Global Peptide Therapeutics Revenue Forecast by Region (2026-2031)
2.2.3 Global Peptide Therapeutics Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Peptide Therapeutics Revenue by Type (2020-2031)
3.1.2 Global Peptide Therapeutics Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Peptide Therapeutics Revenue by Application (2020-2031)
3.2.2 Global Peptide Therapeutics Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Injection of Peptide Therapeutics Revenue Market Share by Application
3.3.2 Oral of Peptide Therapeutics Revenue Market Share by Application
3.3.3 Other of Peptide Therapeutics Revenue Market Share by Application
4 Global Peptide Therapeutics by Company
4.1 Global Peptide Therapeutics Revenue by Company (2020-2025)
4.2 Global Peptide Therapeutics Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Peptide Therapeutics Companies around the World: Ranking by Revenue
4.3.2 Global Peptide Therapeutics Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Peptide Therapeutics Companies Headquarters & Product Type
4.4.1 Global Peptide Therapeutics Companies Headquarters
4.4.2 Date of International Companies Enter into Peptide Therapeutics Market
4.4.3 Global Peptide Therapeutics Companies Product & Service
4.4.4 Injection Revenue Market Share of Peptide Therapeutics by Company
4.4.5 Oral Revenue Market Share of Peptide Therapeutics by Company
4.4.6 Other Revenue Market Share of Peptide Therapeutics by Company
4.5 Global Peptide Therapeutics Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sanofi
5.1.1 Sanofi Corporation Information
5.1.2 Sanofi Description, Business Overview
5.1.3 Sanofi Peptide Therapeutics Products Offered
5.1.4 Sanofi Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.1.5 Sanofi Peptide Therapeutics Revenue by Product in 2024
5.1.6 Sanofi Peptide Therapeutics Revenue by Application in 2024
5.1.7 Sanofi Peptide Therapeutics Revenue by Geographic Area in 2024
5.1.8 Sanofi Recent Developments
5.2 Teva
5.2.1 Teva Corporation Information
5.2.2 Teva Description, Business Overview
5.2.3 Teva Peptide Therapeutics Products Offered
5.2.4 Teva Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.2.5 Teva Peptide Therapeutics Revenue by Product in 2024
5.2.6 Teva Peptide Therapeutics Revenue by Application in 2024
5.2.7 Teva Peptide Therapeutics Revenue by Geographic Area in 2024
5.2.8 Teva Recent Developments
5.3 Novo Nordisk
5.3.1 Novo Nordisk Corporation Information
5.3.2 Novo Nordisk Description, Business Overview
5.3.3 Novo Nordisk Peptide Therapeutics Products Offered
5.3.4 Novo Nordisk Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.3.5 Novo Nordisk Peptide Therapeutics Revenue by Product in 2024
5.3.6 Novo Nordisk Peptide Therapeutics Revenue by Application in 2024
5.3.7 Novo Nordisk Peptide Therapeutics Revenue by Geographic Area in 2024
5.3.8 Novo Nordisk Recent Developments
5.4 Takeda
5.4.1 Takeda Corporation Information
5.4.2 Takeda Description, Business Overview
5.4.3 Takeda Peptide Therapeutics Products Offered
5.4.4 Takeda Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.4.5 Takeda Peptide Therapeutics Revenue by Product in 2024
5.4.6 Takeda Peptide Therapeutics Revenue by Application in 2024
5.4.7 Takeda Peptide Therapeutics Revenue by Geographic Area in 2024
5.4.8 Takeda Recent Developments
5.5 Eli Lilly
5.5.1 Eli Lilly Corporation Information
5.5.2 Eli Lilly Description, Business Overview
5.5.3 Eli Lilly Peptide Therapeutics Products Offered
5.5.4 Eli Lilly Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.5.5 Eli Lilly Peptide Therapeutics Revenue by Product in 2024
5.5.6 Eli Lilly Peptide Therapeutics Revenue by Application in 2024
5.5.7 Eli Lilly Peptide Therapeutics Revenue by Geographic Area in 2024
5.5.8 Eli Lilly Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Corporation Information
5.6.2 AstraZeneca Description, Business Overview
5.6.3 AstraZeneca Peptide Therapeutics Products Offered
5.6.4 AstraZeneca Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.6.5 AstraZeneca Peptide Therapeutics Revenue by Product in 2024
5.6.6 AstraZeneca Peptide Therapeutics Revenue by Application in 2024
5.6.7 AstraZeneca Peptide Therapeutics Revenue by Geographic Area in 2024
5.6.8 AstraZeneca Recent Developments
5.7 Novartis
5.7.1 Novartis Corporation Information
5.7.2 Novartis Description, Business Overview
5.7.3 Novartis Peptide Therapeutics Products Offered
5.7.4 Novartis Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.7.5 Novartis Peptide Therapeutics Revenue by Product in 2024
5.7.6 Novartis Peptide Therapeutics Revenue by Application in 2024
5.7.7 Novartis Peptide Therapeutics Revenue by Geographic Area in 2024
5.7.8 Novartis Recent Developments
5.8 AbbVie
5.8.1 AbbVie Corporation Information
5.8.2 AbbVie Description, Business Overview
5.8.3 AbbVie Peptide Therapeutics Products Offered
5.8.4 AbbVie Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.8.5 AbbVie Peptide Therapeutics Revenue by Product in 2024
5.8.6 AbbVie Peptide Therapeutics Revenue by Application in 2024
5.8.7 AbbVie Peptide Therapeutics Revenue by Geographic Area in 2024
5.8.8 AbbVie Recent Developments
5.9 Ipsen
5.9.1 Ipsen Corporation Information
5.9.2 Ipsen Description, Business Overview
5.9.3 Ipsen Peptide Therapeutics Products Offered
5.9.4 Ipsen Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.9.5 Ipsen Peptide Therapeutics Revenue by Product in 2024
5.9.6 Ipsen Peptide Therapeutics Revenue by Application in 2024
5.9.7 Ipsen Peptide Therapeutics Revenue by Geographic Area in 2024
5.9.8 Ipsen Recent Developments
5.10 Ferring
5.10.1 Ferring Corporation Information
5.10.2 Ferring Description, Business Overview
5.10.3 Ferring Peptide Therapeutics Products Offered
5.10.4 Ferring Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.10.5 Ferring Peptide Therapeutics Revenue by Product in 2024
5.10.6 Ferring Peptide Therapeutics Revenue by Application in 2024
5.10.7 Ferring Peptide Therapeutics Revenue by Geographic Area in 2024
5.10.8 Ferring Recent Developments
5.11 Merck
5.11.1 Merck Corporation Information
5.11.2 Merck Description, Business Overview
5.11.3 Merck Peptide Therapeutics Products Offered
5.11.4 Merck Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.11.5 Merck Peptide Therapeutics Revenue by Product in 2024
5.11.6 Merck Peptide Therapeutics Revenue by Application in 2024
5.11.7 Merck Peptide Therapeutics Revenue by Geographic Area in 2024
5.11.8 Merck Recent Developments
5.12 The Medicines
5.12.1 The Medicines Corporation Information
5.12.2 The Medicines Description, Business Overview
5.12.3 The Medicines Peptide Therapeutics Products Offered
5.12.4 The Medicines Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.12.5 The Medicines Peptide Therapeutics Revenue by Product in 2024
5.12.6 The Medicines Peptide Therapeutics Revenue by Application in 2024
5.12.7 The Medicines Peptide Therapeutics Revenue by Geographic Area in 2024
5.12.8 The Medicines Recent Developments
5.13 J & J
5.13.1 J & J Corporation Information
5.13.2 J & J Description, Business Overview
5.13.3 J & J Peptide Therapeutics Products Offered
5.13.4 J & J Peptide Therapeutics Revenue and Gross Margin (2020-2025)
5.13.5 J & J Peptide Therapeutics Revenue by Product in 2024
5.13.6 J & J Peptide Therapeutics Revenue by Application in 2024
5.13.7 J & J Peptide Therapeutics Revenue by Geographic Area in 2024
5.13.8 J & J Recent Developments
6 North America
6.1 North America Peptide Therapeutics Market Size YoY Growth 2020-2031
6.2 North America Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
6.3 North America Peptide Therapeutics Revenue by Type (2020-2025)
6.4 North America Peptide Therapeutics Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Peptide Therapeutics Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Peptide Therapeutics Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Peptide Therapeutics Revenue by Type (2020-2025)
7.4 Asia-Pacific Peptide Therapeutics Revenue by Application (2020-2025)
8 Europe
8.1 Europe Peptide Therapeutics Market Size YoY Growth 2020-2031
8.2 Europe Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
8.3 Europe Peptide Therapeutics Revenue by Type (2020-2025)
8.4 Europe Peptide Therapeutics Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Peptide Therapeutics Market Size YoY Growth 2020-2031
9.2 Latin America Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
9.3 Latin America Peptide Therapeutics Revenue by Type (2020-2025)
9.4 Latin America Peptide Therapeutics Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Peptide Therapeutics Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Peptide Therapeutics Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Peptide Therapeutics Revenue by Type (2020-2025)
10.4 Middle East and Africa Peptide Therapeutics Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Peptide Therapeutics Supply Chain Analysis
11.2 Peptide Therapeutics Key Raw Materials and Upstream Suppliers
11.3 Peptide Therapeutics Clients Analysis
11.4 Peptide Therapeutics Sales Channel and Sales Model Analysis
11.4.1 Peptide Therapeutics Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Peptide Therapeutics Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Peptide Therapeutics Distributors
12 Peptide Therapeutics Market Dynamics
12.1 Peptide Therapeutics Industry Trends
12.2 Peptide Therapeutics Market Drivers
12.3 Peptide Therapeutics Market Challenges
12.4 Peptide Therapeutics Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Peptide Therapeutics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Peptide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Peptide Therapeutics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Peptide Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Peptide Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Peptide Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Peptide Therapeutics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Peptide Therapeutics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Peptide Therapeutics Players by Revenue (US$ Million) in 2024
Table 13. Global Peptide Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Peptide Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)
Table 15. Global Peptide Therapeutics Companies Headquarters
Table 16. Date of International Companies Enter into Peptide Therapeutics Market
Table 17. Global Peptide Therapeutics Companies Product & Service
Table 18. Global Peptide Therapeutics Mergers & Acquisitions, Expansion Plans
Table 19. Sanofi Corporation Information
Table 20. Sanofi Description and Business Overview
Table 21. Sanofi Peptide Therapeutics Product
Table 22. Sanofi Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Sanofi Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 24. Sanofi Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 25. Sanofi Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 26. Sanofi Recent Developments
Table 27. Teva Corporation Information
Table 28. Teva Description and Business Overview
Table 29. Teva Peptide Therapeutics Product
Table 30. Teva Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Teva Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 32. Teva Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 33. Teva Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 34. Teva Recent Developments
Table 35. Novo Nordisk Corporation Information
Table 36. Novo Nordisk Description and Business Overview
Table 37. Novo Nordisk Peptide Therapeutics Product
Table 38. Novo Nordisk Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 40. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 41. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 42. Novo Nordisk Recent Developments
Table 43. Takeda Corporation Information
Table 44. Takeda Description and Business Overview
Table 45. Takeda Peptide Therapeutics Product
Table 46. Takeda Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Takeda Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 48. Takeda Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 49. Takeda Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 50. Takeda Recent Developments
Table 51. Eli Lilly Corporation Information
Table 52. Eli Lilly Description and Business Overview
Table 53. Eli Lilly Peptide Therapeutics Product
Table 54. Eli Lilly Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Eli Lilly Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 56. Eli Lilly Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 57. Eli Lilly Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 58. Eli Lilly Recent Developments
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Description and Business Overview
Table 61. AstraZeneca Peptide Therapeutics Product
Table 62. AstraZeneca Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. AstraZeneca Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 64. AstraZeneca Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 65. AstraZeneca Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 66. AstraZeneca Recent Developments
Table 67. Novartis Corporation Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Peptide Therapeutics Product
Table 70. Novartis Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Novartis Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 72. Novartis Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 73. Novartis Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 74. Novartis Recent Developments
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Peptide Therapeutics Product
Table 78. AbbVie Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. AbbVie Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 80. AbbVie Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 81. AbbVie Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 82. AbbVie Recent Developments
Table 83. Ipsen Corporation Information
Table 84. Ipsen Description and Business Overview
Table 85. Ipsen Peptide Therapeutics Product
Table 86. Ipsen Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Ipsen Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 88. Ipsen Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 89. Ipsen Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 90. Ipsen Recent Developments
Table 91. Ferring Corporation Information
Table 92. Ferring Description and Business Overview
Table 93. Ferring Peptide Therapeutics Product
Table 94. Ferring Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Ferring Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 96. Ferring Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 97. Ferring Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 98. Ferring Recent Developments
Table 99. Merck Corporation Information
Table 100. Merck Description and Business Overview
Table 101. Merck Peptide Therapeutics Product
Table 102. Merck Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Merck Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 104. Merck Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 105. Merck Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 106. Merck Recent Developments
Table 107. The Medicines Corporation Information
Table 108. The Medicines Description and Business Overview
Table 109. The Medicines Peptide Therapeutics Product
Table 110. The Medicines Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. The Medicines Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 112. The Medicines Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 113. The Medicines Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 114. The Medicines Recent Developments
Table 115. J & J Corporation Information
Table 116. J & J Description and Business Overview
Table 117. J & J Peptide Therapeutics Product
Table 118. J & J Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. J & J Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 120. J & J Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 121. J & J Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 122. J & J Recent Developments
Table 123. North America Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 124. North America Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 125. North America Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 126. North America Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 127. Asia-Pacific Peptide Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 128. Asia-Pacific Peptide Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 129. Asia-Pacific Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 130. Asia-Pacific Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 131. Europe Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 132. Europe Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 133. Europe Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 134. Europe Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 135. Latin America Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 136. Latin America Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 137. Latin America Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 138. Latin America Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 139. Middle East and Africa Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 140. Middle East and Africa Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 141. Middle East and Africa Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 142. Middle East and Africa Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 143. Peptide Therapeutics Key Raw Materials, Industry Status and Trend
Table 144. Peptide Therapeutics Key Raw Materials and Upstream Suppliers
Table 145. Peptide Therapeutics Clients Status and Trend
Table 146. Peptide Therapeutics Typical Clients
Table 147. Peptide Therapeutics Distributors
Table 148. Peptide Therapeutics Market Trends
Table 149. Peptide Therapeutics Market Drivers
Table 150. Peptide Therapeutics Market Challenges
Table 151. Peptide Therapeutics Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapeutics Product Picture
Figure 2. Global Peptide Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Peptide Therapeutics Revenue Market Share by Type in 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Oral Product Picture
Figure 6. Other Product Picture
Figure 7. Global Peptide Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Peptide Therapeutics Revenue Market Share by Application in 2024 & 2031
Figure 9. Cancer
Figure 10. Metabolic Disorders
Figure 11. Central Nervous System
Figure 12. Other
Figure 13. Peptide Therapeutics Report Years Considered
Figure 14. Global Peptide Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Peptide Therapeutics Market Size (2020-2031) & (US$ Million)
Figure 16. Global Peptide Therapeutics Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Peptide Therapeutics Revenue Market Share by Region (2020-2031)
Figure 18. Global Peptide Therapeutics Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Peptide Therapeutics Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Injection of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 21. Oral of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Other of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Peptide Therapeutics Revenue Share by Company (2024)
Figure 24. Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Injection Revenue Proportion by Company in 2024
Figure 26. Oral Revenue Proportion by Company in 2024
Figure 27. Other Revenue Proportion by Company in 2024
Figure 28. North America Peptide Therapeutics Revenue 2020-2031 (US$ Million)
Figure 29. North America Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 30. North America Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Peptide Therapeutics Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Peptide Therapeutics Revenue Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 34. Asia-Pacific Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 35. Europe Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Europe Peptide Therapeutics Revenue Market Share by Country (2020-2031)
Figure 37. Europe Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 38. Europe Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 39. Latin America Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Latin America Peptide Therapeutics Revenue Market Share by Country (2020-2031)
Figure 41. Latin America Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 42. Latin America Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 43. Middle East and Africa Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Middle East and Africa Peptide Therapeutics Revenue Market Share by Country (2020-2031)
Figure 45. Middle East and Africa Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 46. Middle East and Africa Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 47. Peptide Therapeutics Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Peptide Therapeutics Raw Materials by Region in 2024
Figure 49. Peptide Therapeutics Distribution Channels
Figure 50. Global Peptide Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 51. Global Peptide Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Table 1. Global Peptide Therapeutics Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Peptide Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Peptide Therapeutics Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Peptide Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Peptide Therapeutics Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Peptide Therapeutics Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Peptide Therapeutics Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Peptide Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 11. Peptide Therapeutics Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Peptide Therapeutics Players by Revenue (US$ Million) in 2024
Table 13. Global Peptide Therapeutics Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Peptide Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide Therapeutics as of 2024)
Table 15. Global Peptide Therapeutics Companies Headquarters
Table 16. Date of International Companies Enter into Peptide Therapeutics Market
Table 17. Global Peptide Therapeutics Companies Product & Service
Table 18. Global Peptide Therapeutics Mergers & Acquisitions, Expansion Plans
Table 19. Sanofi Corporation Information
Table 20. Sanofi Description and Business Overview
Table 21. Sanofi Peptide Therapeutics Product
Table 22. Sanofi Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Sanofi Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 24. Sanofi Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 25. Sanofi Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 26. Sanofi Recent Developments
Table 27. Teva Corporation Information
Table 28. Teva Description and Business Overview
Table 29. Teva Peptide Therapeutics Product
Table 30. Teva Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Teva Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 32. Teva Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 33. Teva Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 34. Teva Recent Developments
Table 35. Novo Nordisk Corporation Information
Table 36. Novo Nordisk Description and Business Overview
Table 37. Novo Nordisk Peptide Therapeutics Product
Table 38. Novo Nordisk Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 40. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 41. Novo Nordisk Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 42. Novo Nordisk Recent Developments
Table 43. Takeda Corporation Information
Table 44. Takeda Description and Business Overview
Table 45. Takeda Peptide Therapeutics Product
Table 46. Takeda Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Takeda Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 48. Takeda Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 49. Takeda Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 50. Takeda Recent Developments
Table 51. Eli Lilly Corporation Information
Table 52. Eli Lilly Description and Business Overview
Table 53. Eli Lilly Peptide Therapeutics Product
Table 54. Eli Lilly Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Eli Lilly Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 56. Eli Lilly Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 57. Eli Lilly Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 58. Eli Lilly Recent Developments
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Description and Business Overview
Table 61. AstraZeneca Peptide Therapeutics Product
Table 62. AstraZeneca Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. AstraZeneca Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 64. AstraZeneca Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 65. AstraZeneca Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 66. AstraZeneca Recent Developments
Table 67. Novartis Corporation Information
Table 68. Novartis Description and Business Overview
Table 69. Novartis Peptide Therapeutics Product
Table 70. Novartis Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Novartis Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 72. Novartis Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 73. Novartis Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 74. Novartis Recent Developments
Table 75. AbbVie Corporation Information
Table 76. AbbVie Description and Business Overview
Table 77. AbbVie Peptide Therapeutics Product
Table 78. AbbVie Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. AbbVie Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 80. AbbVie Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 81. AbbVie Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 82. AbbVie Recent Developments
Table 83. Ipsen Corporation Information
Table 84. Ipsen Description and Business Overview
Table 85. Ipsen Peptide Therapeutics Product
Table 86. Ipsen Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Ipsen Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 88. Ipsen Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 89. Ipsen Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 90. Ipsen Recent Developments
Table 91. Ferring Corporation Information
Table 92. Ferring Description and Business Overview
Table 93. Ferring Peptide Therapeutics Product
Table 94. Ferring Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Ferring Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 96. Ferring Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 97. Ferring Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 98. Ferring Recent Developments
Table 99. Merck Corporation Information
Table 100. Merck Description and Business Overview
Table 101. Merck Peptide Therapeutics Product
Table 102. Merck Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Merck Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 104. Merck Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 105. Merck Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 106. Merck Recent Developments
Table 107. The Medicines Corporation Information
Table 108. The Medicines Description and Business Overview
Table 109. The Medicines Peptide Therapeutics Product
Table 110. The Medicines Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. The Medicines Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 112. The Medicines Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 113. The Medicines Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 114. The Medicines Recent Developments
Table 115. J & J Corporation Information
Table 116. J & J Description and Business Overview
Table 117. J & J Peptide Therapeutics Product
Table 118. J & J Peptide Therapeutics Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. J & J Revenue Proportion of Peptide Therapeutics by Product in 2024
Table 120. J & J Revenue Proportion of Peptide Therapeutics by Application in 2024
Table 121. J & J Revenue Proportion of Peptide Therapeutics by Geographic Area in 2024
Table 122. J & J Recent Developments
Table 123. North America Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 124. North America Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 125. North America Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 126. North America Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 127. Asia-Pacific Peptide Therapeutics Revenue by Region (2020-2025) & (US$ Million)
Table 128. Asia-Pacific Peptide Therapeutics Revenue by Region (2026-2031) & (US$ Million)
Table 129. Asia-Pacific Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 130. Asia-Pacific Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 131. Europe Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 132. Europe Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 133. Europe Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 134. Europe Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 135. Latin America Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 136. Latin America Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 137. Latin America Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 138. Latin America Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 139. Middle East and Africa Peptide Therapeutics Revenue by Country (2020-2025) & (US$ Million)
Table 140. Middle East and Africa Peptide Therapeutics Revenue by Country (2026-2031) & (US$ Million)
Table 141. Middle East and Africa Peptide Therapeutics Revenue by Type (2020-2025) & (US$ Million)
Table 142. Middle East and Africa Peptide Therapeutics Revenue by Application (2020-2025) & (US$ Million)
Table 143. Peptide Therapeutics Key Raw Materials, Industry Status and Trend
Table 144. Peptide Therapeutics Key Raw Materials and Upstream Suppliers
Table 145. Peptide Therapeutics Clients Status and Trend
Table 146. Peptide Therapeutics Typical Clients
Table 147. Peptide Therapeutics Distributors
Table 148. Peptide Therapeutics Market Trends
Table 149. Peptide Therapeutics Market Drivers
Table 150. Peptide Therapeutics Market Challenges
Table 151. Peptide Therapeutics Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Therapeutics Product Picture
Figure 2. Global Peptide Therapeutics Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Peptide Therapeutics Revenue Market Share by Type in 2024 & 2031
Figure 4. Injection Product Picture
Figure 5. Oral Product Picture
Figure 6. Other Product Picture
Figure 7. Global Peptide Therapeutics Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Peptide Therapeutics Revenue Market Share by Application in 2024 & 2031
Figure 9. Cancer
Figure 10. Metabolic Disorders
Figure 11. Central Nervous System
Figure 12. Other
Figure 13. Peptide Therapeutics Report Years Considered
Figure 14. Global Peptide Therapeutics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Peptide Therapeutics Market Size (2020-2031) & (US$ Million)
Figure 16. Global Peptide Therapeutics Market Size Market Share by Region: 2024 Versus 2031
Figure 17. Global Peptide Therapeutics Revenue Market Share by Region (2020-2031)
Figure 18. Global Peptide Therapeutics Revenue Market Share Forecast by Type (2020-2031)
Figure 19. Global Peptide Therapeutics Revenue Market Share Forecast by Application (2020-2031)
Figure 20. Injection of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 21. Oral of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 22. Other of Peptide Therapeutics Revenue Market Share by Application, 2024 VS 2031
Figure 23. Peptide Therapeutics Revenue Share by Company (2024)
Figure 24. Peptide Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Injection Revenue Proportion by Company in 2024
Figure 26. Oral Revenue Proportion by Company in 2024
Figure 27. Other Revenue Proportion by Company in 2024
Figure 28. North America Peptide Therapeutics Revenue 2020-2031 (US$ Million)
Figure 29. North America Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 30. North America Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 31. Asia-Pacific Peptide Therapeutics Revenue 2020-2031 (US$ Million)
Figure 32. Asia-Pacific Peptide Therapeutics Revenue Market Share by Region (2020-2031)
Figure 33. Asia-Pacific Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 34. Asia-Pacific Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 35. Europe Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 36. Europe Peptide Therapeutics Revenue Market Share by Country (2020-2031)
Figure 37. Europe Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 38. Europe Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 39. Latin America Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 40. Latin America Peptide Therapeutics Revenue Market Share by Country (2020-2031)
Figure 41. Latin America Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 42. Latin America Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 43. Middle East and Africa Peptide Therapeutics Revenue Growth Rate 2020-2031 (US$ Million)
Figure 44. Middle East and Africa Peptide Therapeutics Revenue Market Share by Country (2020-2031)
Figure 45. Middle East and Africa Peptide Therapeutics Revenue Market Share by Type (2020-2025)
Figure 46. Middle East and Africa Peptide Therapeutics Revenue Market Share by Application (2020-2025)
Figure 47. Peptide Therapeutics Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Peptide Therapeutics Raw Materials by Region in 2024
Figure 49. Peptide Therapeutics Distribution Channels
Figure 50. Global Peptide Therapeutics Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 51. Global Peptide Therapeutics Percentage 2020-2031: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Allergen Detection Market Research Report 2025
Jun 28, 25
Global Electronic Health Tracking System Market Research Report 2025
Jun 28, 25
Global Speciality Optical Fibers Market Research Report 2025
Jun 28, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232